|
|
 |
|
Viewing report
|
|
 |
 |
Stada Pharma Partnering Guide 2008
CurrentPartnering, July 2008, Pages: 46
The Stada Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Stada and its partnering interests and activities over the past five years.
One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.
Using this report, dealmakers will effectively and efficiently determine the suitablility of Stada as a prospective partner, their business development objectives, interests and recent partnering activity, key partnering contacts, and partnering contract documents signed with their recent partners.
The report provides a firm basis for initial due diligence into Stada as a prospective partner company.
Key Benefits: Stada Partnering Guide 2008 report provides the user with the following key benefits:
- Detailed company profile of the company - In-depth marketed and pipeline product activity for the company - Partnering interests and therapy focus revealed - Partnering activity since 2000 – number of deals per year
Partnering activity for 2005-2008: - Activity by deal type - Activity by phase of development - Activity by therapeutic area
List of recent partner companies: - Comprehensive access to actual contracts entered into by the company and its partners* - Insight into the terms included in a partnering agreement - Understand the key deal terms the company has agreed in previous deals - Undertake due diligence to assess suitability of your proposed deal terms for partner companies *Subject to being published via regulatory requirements of the Securities Exchange Commission.
Report Scope: Stada Partnering Guide 2008 is intended to provide the reader with an in-depth understanding of the partnering activities and interests of the company, enabling the effective assessment and selection of partners of choice, based on the latest knowledge of a company’s approach to partnering.
Stada Partnering Guide 2008 includes:
Detailed company profile including: - Full contact details - Business developer contact details including name, title, email and telephone (where available) - Marketed indications - Pipeline indications - Partnering interests and indications - Partnering activity since 2000 - Current partner companies since 2005
Partnering activity since 2005 by: - Deal type - Stage of development - Therapy area
- Numerous charts showing the dealmaking activity of the company since 2005 - The tools to enable effective and efficient preparation for partnering negotiation with the company - Listing of contract documents between the company and its partners - The leading M&A and partnering deals by value 2005-8 - Most active M&A and partnering dealmakers 2005-8
Customers who bought this item also bought
Partnering?with Bigpharma: The Definitive Guide to Partnering Interests, Contacts & Agreements
Barr Pharma Partnering Guide 2008
Bigpharma Partnering Agreements
Stada Arzneimittel Generics Company Intelligence Report
Stada IMS Company Profile
Distribution Agreements?in Biopharma
Bigpharma Dealmaking Handbook 2007
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
|
 |
|
|